Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Moore

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Journal of Applied Clinical Medical Physics|June 13, 2018
Data integrity systems for organ contours in radiation therapy planningVeeraj P Shah, Pranav Lakshminarayanan, Joseph Moore, et al.
Leukemia & Lymphoma|March 25, 2010
Histiocytic sarcoma arising in indolent small B-cell lymphoma: report of two cases with molecular/genetic evidence suggestive of a 'transdifferentiation' during the clonal evolutionEndi Wang, Charles Blake Hutchinson, Qin Huang, et al.
JMIR Serious Games|January 10, 2023
Usability of the GAIMplank Video Game Controller for People With Mobility Impairments: Observational StudyLaurie A Malone, Christen J Mendonca, Sangeetha Mohanraj, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2018
Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin LymphomaBenjamin Heyman, David Rizzieri, David J Adams, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 1, 2010
Phase I study of temozolomide and laromustine (VNP40101M) in patients with relapsed or refractory leukemiaDavid Rizzieri, Samantha LoRusso, William Tse, et al.
Cancer Investigation|October 13, 2021
Phase II Study of Single-Agent and Combination Everolimus and Panobinostat in Relapsed or Refractory Diffuse Large B-Cell LymphomaPrioty Islam, David Rizzieri, Chenyu Lin, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|March 3, 2025
Evaluation of long-term outcomes with intrathecal opioid treatment: a comparison utilizing data derived from pain clinic populations in Australia and New ZealandElouise Rose Comber, Jenny Strong, Orla Moore, et al.
American Journal of Hematology|May 16, 2003
Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanerceptJ R McMinn, Stephen Cohen, Joseph Moore, et al.
International Journal of Molecular Sciences|June 19, 2024
Osteoarthritis as a Systemic Disease Promoted Prostate Cancer In Vivo and In VitroSamuel Rosas, Andy Kwok, Joseph Moore, et al.
Advances in Radiation Oncology|February 14, 2020
Tumor-Treating Field Arrays Do Not Reduce Target Volume Coverage for Glioblastoma Radiation TherapyGregory C Stachelek, Jimm Grimm, Joseph Moore, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Journal of Applied Clinical Medical Physics|June 13, 2018
Data integrity systems for organ contours in radiation therapy planningVeeraj P Shah, Pranav Lakshminarayanan, Joseph Moore, et al.
Leukemia & Lymphoma|March 25, 2010
Histiocytic sarcoma arising in indolent small B-cell lymphoma: report of two cases with molecular/genetic evidence suggestive of a 'transdifferentiation' during the clonal evolutionEndi Wang, Charles Blake Hutchinson, Qin Huang, et al.
JMIR Serious Games|January 10, 2023
Usability of the GAIMplank Video Game Controller for People With Mobility Impairments: Observational StudyLaurie A Malone, Christen J Mendonca, Sangeetha Mohanraj, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2018
Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin LymphomaBenjamin Heyman, David Rizzieri, David J Adams, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 1, 2010
Phase I study of temozolomide and laromustine (VNP40101M) in patients with relapsed or refractory leukemiaDavid Rizzieri, Samantha LoRusso, William Tse, et al.
Cancer Investigation|October 13, 2021
Phase II Study of Single-Agent and Combination Everolimus and Panobinostat in Relapsed or Refractory Diffuse Large B-Cell LymphomaPrioty Islam, David Rizzieri, Chenyu Lin, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|March 3, 2025
Evaluation of long-term outcomes with intrathecal opioid treatment: a comparison utilizing data derived from pain clinic populations in Australia and New ZealandElouise Rose Comber, Jenny Strong, Orla Moore, et al.
American Journal of Hematology|May 16, 2003
Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanerceptJ R McMinn, Stephen Cohen, Joseph Moore, et al.
International Journal of Molecular Sciences|June 19, 2024
Osteoarthritis as a Systemic Disease Promoted Prostate Cancer In Vivo and In VitroSamuel Rosas, Andy Kwok, Joseph Moore, et al.
Advances in Radiation Oncology|February 14, 2020
Tumor-Treating Field Arrays Do Not Reduce Target Volume Coverage for Glioblastoma Radiation TherapyGregory C Stachelek, Jimm Grimm, Joseph Moore, et al.
Pageof 7